OBSOLETE: Common variable immunodeficiency due to TNFR deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:183672
Who is this for?
Show terms as
3Active trials8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Common variable immunodeficiency due to TNFR (tumor necrosis factor receptor) deficiency is a condition that was previously classified as a distinct form of common variable immunodeficiency (CVID). It is now considered an obsolete classification, meaning that the medical community has reclassified or merged this condition into broader or updated disease categories. CVID in general is a group of immune system disorders where the body cannot make enough protective antibodies (immunoglobulins), leaving a person vulnerable to frequent and sometimes severe infections. In this particular subtype, the underlying problem was thought to involve defects in the TNFR signaling pathway, which plays an important role in how immune cells communicate and respond to threats. Patients with this type of immune deficiency typically experienced repeated bacterial infections, particularly of the lungs, sinuses, and ears. Some patients also developed autoimmune problems, where the immune system mistakenly attacks the body's own tissues, or had enlarged lymph nodes and spleen. Because this classification is now obsolete, patients who were previously diagnosed with this condition may have been reclassified under other forms of CVID or primary immunodeficiency. Treatment generally involves immunoglobulin replacement therapy, which provides the missing antibodies, along with antibiotics to treat and prevent infections. Patients should work closely with an immunologist to ensure they receive the most up-to-date diagnosis and management plan.

Also known as:

Key symptoms:

Frequent sinus infectionsRecurring lung infections or pneumoniaChronic ear infectionsFrequent stomach or intestinal infections with diarrheaEnlarged lymph nodesEnlarged spleenAutoimmune problems such as low blood cell countsUnexplained weight lossFatigue and low energyJoint pain or swellingSkin rashes or granulomasPoor response to vaccines

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

3 events
Jan 2024Usage of Spirometry in Managing IgG Therapy in CVID with Airway Disease

University of Alabama at Birmingham — PHASE4

TrialRECRUITING
Apr 2023Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency

Avni Joshi — PHASE2

TrialENROLLING BY INVITATION
Nov 2015Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

National Cancer Institute (NCI) — PHASE2

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Common variable immunodeficiency due to TNFR deficiency.

3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

3 recruitingView all trials with filters →
Phase 41 trial
Usage of Spirometry in Managing IgG Therapy in CVID with Airway Disease
Phase 4
Actively Recruiting
PI: Harry Schroeder, MD/PhD (University of Alabama at Birmingham) · Sites: Birmingham, Alabama · Age: 2199 yrs
Phase 22 trials
Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency
Phase 2
Enrolling by Invitation
PI: Avni Joshi, MD, MS (Mayo Clinic) · Sites: Rochester, Minnesota · Age: 1899 yrs
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Phase 2
Actively Recruiting
PI: Dimana Dimitrova, M.D. (National Cancer Institute (NCI)) · Sites: Bethesda, Maryland; Minneapolis, Minnesota · Age: 475 yrs

No specialists are currently listed for OBSOLETE: Common variable immunodeficiency due to TNFR deficiency.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Common variable immunodeficiency due to TNFR deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Common variable immunodeficiency due to TNFR deficiencyForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Common variable immunodeficiency due to TNFR deficiency.

Start the conversation →

Latest news about OBSOLETE: Common variable immunodeficiency due to TNFR deficiency

No recent news articles for OBSOLETE: Common variable immunodeficiency due to TNFR deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Since this classification is now obsolete, what is my most accurate current diagnosis?,Should I have updated genetic testing to better understand my condition?,What type of immunoglobulin replacement therapy is best for me — IV or subcutaneous?,How often should I have my immunoglobulin levels and lung function checked?,What vaccines are safe for me, and which ones should I avoid?,What signs of infection or complications should prompt me to seek emergency care?,Are my family members at risk, and should they be tested?

Common questions about OBSOLETE: Common variable immunodeficiency due to TNFR deficiency

What is OBSOLETE: Common variable immunodeficiency due to TNFR deficiency?

Common variable immunodeficiency due to TNFR (tumor necrosis factor receptor) deficiency is a condition that was previously classified as a distinct form of common variable immunodeficiency (CVID). It is now considered an obsolete classification, meaning that the medical community has reclassified or merged this condition into broader or updated disease categories. CVID in general is a group of immune system disorders where the body cannot make enough protective antibodies (immunoglobulins), leaving a person vulnerable to frequent and sometimes severe infections. In this particular subtype, th

Are there clinical trials for OBSOLETE: Common variable immunodeficiency due to TNFR deficiency?

Yes — 3 recruiting clinical trials are currently listed for OBSOLETE: Common variable immunodeficiency due to TNFR deficiency on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.